Bio-Techne
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $289,458 | $306,098 | $303,428 | $272,598 |
Gross Profit | 202,758 | 204,875 | 205,246 | 176,587 |
EBITDA | 40,171 | 107,047 | 99,291 | 65,519 |
EBIT | 39,987 | 78,990 | 71,980 | 37,716 |
Net Income | 33,600 | 40,588 | 49,059 | 27,465 |
Net Change In Cash | 289,458 | 306,098 | 303,428 | 272,598 |
Free Cash Flow | 54,717 | 57,516 | 64,545 | 68,252 |
Cash | 187,540 | 151,791 | 139,915 | 130,132 |
Basic Shares | 161,115 | 160,651 | 160,496 | 160,060 |
Annual Financials
| Values in thousands | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|
Revenue | $1,159,060 | $1,136,702 | $1,105,599 | $931,032 |
Gross Profit | 773,074 | 769,815 | 756,496 | 632,850 |
EBITDA | 364,760 | 406,182 | 397,659 | 237,296 |
EBIT | 253,049 | 298,944 | 296,590 | 149,549 |
Net Income | 168,105 | 285,263 | 272,051 | 140,410 |
Net Change In Cash | 1,159,060 | 1,136,702 | 1,105,599 | 931,032 |
Cost of Revenue | 11,360 | -14,432 | 46,097 | |
Free Cash Flow | 236,104 | 216,149 | 280,364 | 307,863 |
Cash | 151,791 | 180,571 | 172,567 | 199,091 |
Basic Shares | 160,774 | 161,855 | 164,116 | 161,932 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | $0.42 |
2024-06-30 | $0.49 |
2024-03-31 | $0.48 |
2023-12-31 | $0.40 |
